Research Calls
- Upgrades:
- BioXcel Therapeutics (BTAI) upgraded to Neutral from Sell at Goldman; tgt $16
- Cellnex Telecom SA (CLNXF) upgraded to Buy from Neutral at UBS
- Lennox Int'l (LII) upgraded to Overweight from Equal Weight at Wells Fargo; tgt raised to $300
- Navient (NAVI) upgraded to Equal-Weight from Underweight at Morgan Stanley; tgt raised to $16
- Pentair (PNR) upgraded to Overweight from Equal Weight at Barclays; tgt raised to $55
- Regions Fincl (RF) upgraded to Outperform from Peer Perform at Wolfe Research; tgt $24
- SpartanNash (SPTN) upgraded to Buy from Neutral at Northcoast
- StoneCo (STNE) upgraded to Neutral from Sell at Goldman; tgt raised to $11
- Thomson Reuters (TRI) downgraded to Underperform from Neutral at Exane BNP Paribas
- U.S. Bancorp (USB) downgraded to Peer Perform from Outperform at Wolfe Research
- Vontier (VNT) downgraded to Peer Perform from Outperform at Wolfe Research
- Downgrades:
- Ally Financial (ALLY) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $19
- B&G Foods (BGS) downgraded to Underweight from Equal Weight at Consumer Edge Research; tgt $9
- Capital One (COF) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $90
- Eni S.p.A. (E) downgraded to Hold from Buy at HSBC Securities
- Equinor (EQNR) downgraded to Hold from Buy at HSBC Securities
- G-III Apparel (GIII) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $22
- Hubbell (HUBB) downgraded to Underperform from Peer Perform at Wolfe Research; tgt $235
- Leslie's (LESL) downgraded to Hold from Buy at Stifel; tgt lowered to $15
- Liberty Global (LBTYA) downgraded to Neutral from Overweight at JP Morgan; tgt $23
- ONE Gas (OGS) downgraded to Sell from Neutral at Guggenheim; tgt $64
- Otis Worldwide (OTIS) downgraded to Equal Weight from Overweight at Barclays; tgt $80
- PagSeguro Digital (PAGS) downgraded to Sell from Neutral at Goldman; tgt lowered to $9
- Pearson Plc (PSO) downgraded to Neutral from Outperform at Exane BNP Paribas
- Regal Rexnord (RRX) downgraded to Peer Perform from Outperform at Wolfe Research
- Saia (SAIA) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $215
- Sirius XM (SIRI) downgraded to Sell from Buy at Citigroup; tgt lowered to $6
- Synchrony Financial (SYF) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $29
- Others:
- Aclaris Therapeutics (ACRS) initiated with a Buy at Goldman; tgt $25
- ADT (ADT) resumed with a Buy at Citigroup; tgt $11
- Altimmune (ALT) initiated with a Buy at Goldman; tgt $20
- Day One Biopharmaceuticals (DAWN) initiated with a Buy at BofA Securities; tgt $34
- Duck Creek Technologies (DCT) initiated with a Neutral at JP Morgan; tgt $13
- Fusion Pharmaceuticals (FUSN) resumed with a Buy at B. Riley Securities; tgt $10
- GoodRx (GDRX) initiated with a Buy at Citigroup; tgt $7
- Guidewire Software (GWRE) initiated with an Overweight at JP Morgan; tgt $78
- NeoGames (NGMS) initiated with a Buy at Deutsche Bank; tgt $174
- Palo Alto Networks (PANW) initiated with a Buy at Redburn; tgt $270
- RAPT Therapeutics (RAPT) initiated with a Buy at Goldman; tgt $27
- Sapiens Int'l (SPNS) initiated with an Underweight at JP Morgan; tgt $20
- scPharmaceuticals (SCPH) initiated with an Outperform at Cowen; tgt $25
- SentinelOne (S) initiated with a Neutral at Redburn; tgt $18
- SpringWorks Therapeutics (SWTX) initiated with a Buy at BofA Securities; tgt $45
- Sunnova Energy (NOVA) initiated with a Buy at Janney; tgt $33
- Sunrun (RUN) initiated with a Neutral at Janney; tgt $30
- TriplePoint Venture Growth (TPVG) initiated with a Neutral at UBS; tgt $13.50